B. Braun Receives FDA Clearance for AQUAbase® nX Reverse Osmosis System

A Customizable Dialysis Solution that Disinfects without Chemicals BETHLEHEM, Pa., Sept. 18, 2023 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today it has received 510(k) clearance from the U.S. Food and Drug…

Click here to view original post